Log | Progress In Mind

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Brazil newsletter		Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter opened	Tue, 08/04/2020 - 00:51	Opened		Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Brazil newsletter		Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter opened	Tue, 08/04/2020 - 00:51	Opened		Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst

Patrocinado por

Progress in Mind Brazil

INSCRIÇÃO NEWSLETTER